✦ LIBER ✦
Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis
✍ Scribed by Gurion, R.; Gafter-Gvili, A.; Vidal, L.; Leader, A.; Ram, R.; Shacham-Abulafia, A.; Paul, M.; Ben-Bassat, I.; Shpilberg, O.; Raanani, P.
- Book ID
- 118237206
- Publisher
- Ferrata Storti Foundation
- Year
- 2012
- Tongue
- Italian
- Weight
- 915 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0390-6078
No coin nor oath required. For personal study only.